Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines

14Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We studied the cytotoxic effect of various anticancer agents on lymphoblastoid cell lines transformed by Epstein-Barr virus. Post-immortal N0005 (post-N0005) is an immortalized cell line derived from pre-immortal N0005 (pre-N0005) accompanied by increased telomerase activity, short-telomere, abnormal karyotypes, mutation of p53 gene, down regulation of p16/Rb and the ability to grow in soft agar medium. Compared with pre-N0005 cells, post-N0005 cells were significantly (p<0.001 by the Student t test) more resistant to the killing activity of seven DNA-modifying agents: camptothecin, etoposide, bleomycin, fluorouracil, thioguanine, melphalan and actinomycin D. However, both pre-N0005 and post-N0005 cells showed similar levels of cytotoxicity against four DNA-non-modifying agents: colchicine, paclitaxel, vincristine and methotrexate. DNA-modifying and DNA-non-modifying agents are distinguished by their different sensitivities with pre-N0005 and post-N0005. Based on these results, we propose that pre-N0005 and post-N0005 cell lines be used as a new method to assess and screen anticancer agents. © 2005 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Sawada, K., Noda, K., Nakajima, H., Shimbara, N., Furuichi, Y., & Sugimoto, M. (2005). Differential cytotoxicity of anticancer agents in pre- and post-immortal lymphoblastoid cell lines. Biological and Pharmaceutical Bulletin, 28(7), 1202–1207. https://doi.org/10.1248/bpb.28.1202

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free